DRD2 and psychotic disorder: From a mechanistic standpoint, limited but consistent evidence from F-DOPA PET human and animal studies suggested that ulotaront may alleviate presynaptic dopamine dysregulation in the striatum53,59, a central factor in the development of psychosis symptoms75, in contrast to dopamine D2 receptor blocking drugs76,77.